Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking EP 199
Evaluation of Microhematuria: A Risk-based Approach - Frankly Speaking EP 199 is organized by Pri-Med.
Release Date: 11/23/2020
Expiration Date: 11/23/2021
Pri-Med Institute designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Microhematuria is a common finding. It is usually benign, but it needs proper evaluation since it may also be a sign of malignancy. A risk-based approach can avoid unnecessary testing, while still identifying those patients with malignancy. Recent American Urological Association (AUA) guidelines use a validated risk-based approach.
• Assess the risk for malignancy in patients with microhematuria
• Describe a risk-based approach to evaluating microhematuria
Additional details will be posted as soon as information is available.
- CME : 0.25
Number of Health Care Professionals Registered: 0 Number
Toll free Number
Browse CME / CE Conferences by Specialty View All
- Immunology and Microbiology
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes
- Healthcare Management
- Infectious Disease
- Medical Education
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine